Jason P. Rhodes serves as Executive at Epizyme, Inc., where they oversee executive responsibilities. Since joining the company, Jason P. Rhodes has executed 178 insider transactions totaling $111.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2024 involved selling 29,435 shares valued at $884.5K.
Jason P. Rhodes currently holds 1,458,691 shares of Epizyme, Inc. (EPZM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason P. Rhodes has been a net seller of EPZM stock. They have purchased $25.0M and sold $86.5M worth of shares.
Jason P. Rhodes's most recent insider trade was on Mar 1, 2024, when they sold 29,435 shares at $30.05 per share.
Get notified when new Form 4 filings are submitted
| $30.05 |
| Planned |
| Feb 28, 2024 | DYN | $3.8M | Sale | 152,244 | $24.83 | Planned |
| Feb 28, 2024 | DYN | $61.4K | Sale | 2,430 | $25.25 | Planned |
| Feb 28, 2024 | DYN | $560.3K | Sale | 22,567 | $24.83 | Planned |
| Feb 28, 2024 | DYN | $5.3K | Sale | 210 | $25.25 | Planned |
| Feb 28, 2024 | DYN | $325.5K | Sale | 13,109 | $24.83 | Planned |
| Feb 28, 2024 | DYN | $9.1K | Sale | 360 | $25.25 | Planned |
| Feb 27, 2024 | DYN | $573.1K | Sale | 23,505 | $24.38 | Planned |
| Feb 27, 2024 | DYN | $94.3K | Sale | 3,821 | $24.68 | Planned |
| Feb 27, 2024 | DYN | $54.7K | Sale | 2,216 | $24.68 | Planned |
| Feb 27, 2024 | DYN | $986.3K | Sale | 40,455 | $24.38 | Planned |
| Feb 27, 2024 | DYN | $636.2K | Sale | 25,779 | $24.68 | Planned |
| Feb 27, 2024 | DYN | $6.7M | Sale | 272,923 | $24.38 | Planned |
| Feb 26, 2024 | DYN | $133.8K | Sale | 5,580 | $23.98 | Planned |
| Feb 26, 2024 | DYN | $276.9K | Sale | 11,736 | $23.59 | Planned |
| Feb 26, 2024 | DYN | $230.3K | Sale | 9,603 | $23.98 | Planned |
| Feb 26, 2024 | DYN | $476.6K | Sale | 20,205 | $23.59 | Planned |
| Feb 26, 2024 | DYN | $1.6M | Sale | 64,783 | $23.98 | Planned |
| Feb 26, 2024 | DYN | $3.2M | Sale | 136,312 | $23.59 | Planned |
| Feb 23, 2024 | DYN | $3.6M | Sale | 159,542 | $22.70 | Planned |
| Feb 23, 2024 | DYN | $311.9K | Sale | 13,738 | $22.70 | Planned |
| Feb 23, 2024 | DYN | $536.8K | Sale | 23,648 | $22.70 | Planned |
| Feb 22, 2024 | DYN | $2.7M | Sale | 119,360 | $22.66 | Planned |
| Feb 21, 2024 | DYN | $3.4M | Sale | 149,337 | $22.44 | Planned |
| Feb 21, 2024 | DYN | $813.7K | Sale | 35,164 | $23.14 | Planned |
| Feb 20, 2024 | DYN | $82.1K | Sale | 3,510 | $23.40 | Planned |
| Feb 20, 2024 | DYN | $3.8M | Sale | 166,029 | $22.71 | Planned |
| Feb 16, 2024 | DYN | $3.8M | Sale | 162,707 | $23.14 | Planned |
| Feb 15, 2024 | DYN | $4.2M | Sale | 175,793 | $23.88 | Planned |